Seeking Alpha Quant rates LABU as a strong Sell, but I rates it as a Buy due to bullish market conditions. LABU is a leveraged ETF that seeks to track 3x the daily performance of the S&P Biotechnology ...
Pairing Direxion Daily's S&P Biotech Bull 3X Shares ETF with their S&P Biotech Bear 3X Shares ETF produces a low volatility couple. Shorting both assets is attractive because leveraged assets erode ...
The San Diego Zoo’s orangutan exhibit has a new inhabitant fresh out of Fresno. The orangutan group recently welcomed Labu, a 14-year-old male orangutan, who arrived from the Fresno Chaffee Zoo on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results